Innovative monoclonal antibody therapies in multiple sclerosis.
about
The efficacy and safety of daclizumab and its potential role in the treatment of multiple sclerosis.Chemotherapeutics in the treatment of multiple sclerosis.Polyketides with Immunosuppressive Activities from Mangrove Endophytic Fungus Penicillium sp. ZJ-SY₂.Novel treatment for immune neuropathies on the horizon.Preparation of clinical-scale 177 Lu-Rituximab: Optimization of protocols for conjugation, radiolabeling, and freeze-dried kit formulation.
P2860
Innovative monoclonal antibody therapies in multiple sclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Innovative monoclonal antibody therapies in multiple sclerosis.
@en
Innovative monoclonal antibody therapies in multiple sclerosis.
@nl
type
label
Innovative monoclonal antibody therapies in multiple sclerosis.
@en
Innovative monoclonal antibody therapies in multiple sclerosis.
@nl
prefLabel
Innovative monoclonal antibody therapies in multiple sclerosis.
@en
Innovative monoclonal antibody therapies in multiple sclerosis.
@nl
P2860
P356
P1476
Innovative monoclonal antibody therapies in multiple sclerosis.
@en
P2093
Ralf A Linker
P2860
P356
10.1177/1756285608093945
P577
2008-07-01T00:00:00Z